When it reconvenes in September, the US Congress plans to draft and approve a continuing resolution (CR) to maintain federal agencies’ budgets through the first half of fiscal 2013. Also, Congress will choose whether to alter current budgets. Adjustments cannot be made once the CR is in place. The CR could lessen the NSF’s chance […]
According to the Census of Publicly Funded Forensic Crime Laboratories, the estimated 2009 budget for publicly funded crime labs in the US grew 5.7% to $1.6 billion from the previous census in 2005. The Urban Institute collected the data in 2010 and 2011 and received responses from 97% of the 411 publicly funded US crime […]
In 2011, there were 34 partnerships between companion diagnostics makers and drug firms, up 36% from 2010. In the first quarter of 2012, 10 such partnerships were established. In July, QIAGEN’s companion diagnostic for Bristol-Myers Squibb and Eli Lilly’s colorectal cancer treatment Erbitux received FDA approval. Iressa, AstraZeneca’s drug for lung cancer introduced in 2002, […]
In the second quarter, revenues for IBO’s Laboratory Sales Index grew 1.2%, 3.2% excluding currency, to $5,729 million. Operating profit improved 1.4% to $1,153 million. Based on continuing operations, operating margin slipped 30 basis points to 17.6% of sales. For the two companies (Oxford Instruments, Tecan) that did not report earnings before this issue’s publication, […]
Santa Clara, CA 7/25/12—Agilent Technologies has announced that the European Patent Office (EPO) has rejected the claims of and revoked Affymetrix’s EP 0853679 entitled “Expression Monitoring by Hybridization to High Density Oligonucleotide Arrays.” The ruling is the result of an appeal by Agilent, Combimatrix and Clonediag of a previous decision. The case dates back to […]
Tokyo, Japan 7/25/12; Tokyo, Japan 7/25/12; Tokyo, Japan 8/9/12—Hitachi High-Technologies and Seiko Instruments have announced a delay in the acquisition of Seiko’s SII NanoTechnology business by Hitachi High-Technologies (see IBO 5/31/12) due to regulatory review. The Japan Fair Trade Commission (JFTC) has stated that following a review of the impact on the acquisition on competitors, […]
Washington, DC 8/3/12—Waters disclosed in its quarterly filing with the SEC that it has acquired software firm Blue Reference for $14 million in cash. Blue Reference develops and distributes software products for real-time mining of multiple-application scientific databases. The filing stated: “The Company will integrate the Blue Reference technology into the current and future software […]
Carlsbad, CA 7/31/12—Life Technologies announced during its second-quarter earnings conference call that it has acquired Chinese distributor Beijing Maojian United Star Technology. The company is a distributor of Life Technologies’ Invitrogen brand reagents in Beijing and North China. “This acquisition now creates one of the largest direct-selling forces in the life sciences reagents market in […]
Burlington, MA 7/31/12; San Diego, CA 8/1/12; Hillsboro, OR 8/1/12—FEI has acquired Visualization Sciences Group (VSG), a provider of high-performance three-dimensional software products for a range of markets, for $55 million. VSG generated pro forma revenues of $19 million for the year ending June 30. “VSG is an extension and acceleration of our strategy to […]
Earlier this month, Waters announced an exclusive relationship with informatics provider Nonlinear Dynamics. Although the companies have had a comarketing agreement since 2005, the new OEM agreement is for the codevelopment of informatics tools for Waters’s LC/MS platforms. The agreement signifies the progression of Waters’s MS informatics offerings, as well as trends in MS analysis. […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
